Ingalls & Snyder LLC’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,533
| Closed | -$202K | – | 458 |
|
|
2024
Q1 | $202K | Buy |
+1,533
| New | +$191K | 0.01% | 406 |
|
|
2023
Q3 | – | Sell |
-1,639
| Closed | -$239K | – | 463 |
|
|
2023
Q2 | $239K | Buy |
+1,639
| New | +$223K | 0.01% | 382 |
|
|
2022
Q2 | – | Sell |
-2,234
| Closed | -$286K | – | 481 |
|
|
2022
Q1 | $286K | Sell |
2,234
-67
| -3% | -$8.08K | 0.01% | 379 |
|
|
2021
Q4 | $284K | Hold |
2,301
| – | – | 0.01% | 389 |
|
|
2021
Q3 | $327K | Sell |
2,301
-173
| -7% | -$25.4K | 0.02% | 369 |
|
|
2021
Q2 | $386K | Sell |
2,474
-416
| -14% | -$67.4K | 0.02% | 351 |
|
|
2021
Q1 | $449K | Sell |
2,890
-232
| -7% | -$35.9K | 0.02% | 308 |
|
|
2020
Q4 | $467K | Sell |
3,122
-41
| -1% | -$5.79K | 0.02% | 294 |
|
|
2020
Q3 | $418K | Hold |
3,163
| – | – | 0.03% | 263 |
|
|
2020
Q2 | $367K | Hold |
3,163
| – | – | 0.02% | 297 |
|
|
2020
Q1 | $310K | Hold |
3,163
| – | – | 0.02% | 317 |
|
|
2019
Q4 | $460K | Sell |
3,163
-26
| -0.8% | -$3.59K | 0.02% | 273 |
|
|
2019
Q3 | $425K | Hold |
3,189
| – | – | 0.02% | 310 |
|
|
2019
Q2 | $365K | Sell |
3,189
-1,133
| -26% | -$133K | 0.02% | 324 |
|
|
2019
Q1 | $536K | Sell |
4,322
-489
| -10% | -$55.6K | 0.03% | 280 |
|
|
2018
Q4 | $484K | Hold |
4,811
| – | – | 0.03% | 283 |
|
|
2018
Q3 | $614K | Sell |
4,811
-52
| -1% | -$6.18K | 0.03% | 282 |
|
|
2018
Q2 | $526K | Sell |
4,863
-1,622
| -25% | -$177K | 0.02% | 269 |
|
|
2018
Q1 | $687K | Sell |
6,485
-6,913
| -52% | -$803K | 0.03% | 242 |
|
|
2017
Q4 | $1.57M | Sell |
13,398
-6,867
| -34% | -$777K | 0.07% | 175 |
|
|
2017
Q3 | $2.3M | Buy |
20,265
+522
| +3% | +$60.3K | 0.12% | 124 |
|
|
2017
Q2 | $2.46M | Sell |
19,743
-647
| -3% | -$76.7K | 0.13% | 114 |
|
|
2017
Q1 | $2.42M | Sell |
20,390
-170
| -0.8% | -$19.3K | 0.13% | 117 |
|
|
2016
Q4 | $2.06M | Sell |
20,560
-1,324
| -6% | -$142K | 0.11% | 137 |
|
|
2016
Q3 | $2.76M | Sell |
21,884
-1,506
| -6% | -$186K | 0.15% | 107 |
|
|
2016
Q2 | $2.73M | Sell |
23,390
-1
| -0% | -$113 | 0.16% | 109 |
|
|
2016
Q1 | $2.42M | Sell |
23,391
-333
| -1% | -$32.2K | 0.15% | 105 |
|
|
2015
Q4 | $2.36M | Sell |
23,724
-1,532
| -6% | -$150K | 0.15% | 102 |
|
|
2015
Q3 | $2.3M | Sell |
25,256
-967
| -4% | -$96.9K | 0.15% | 102 |
|
|
2015
Q2 | $2.78M | Hold |
26,223
| – | – | 0.15% | 102 |
|
|
2015
Q1 | $2.99M | Sell |
26,223
-657
| -2% | -$75K | 0.16% | 99 |
|
|
2014
Q4 | $2.96M | Sell |
26,880
-435
| -2% | -$45.9K | 0.17% | 98 |
|
|
2014
Q3 | $2.67M | Buy |
27,315
+353
| +1% | +$34.7K | 0.14% | 108 |
|
|
2014
Q2 | $2.72M | Sell |
26,962
-78
| -0.3% | -$7.61K | 0.13% | 109 |
|
|
2014
Q1 | $2.48M | Sell |
27,040
-1,663
| -6% | -$153K | 0.13% | 114 |
|
|
2013
Q4 | $2.6M | Buy |
28,703
+46
| +0.2% | +$3.98K | 0.14% | 110 |
|
|
2013
Q3 | $2.29M | Hold |
28,657
| – | – | 0.14% | 111 |
|
|
2013
Q2 | $2.08M | Buy |
+28,657
| New | +$2.14M | 0.13% | 118 |
|
Other funds holding ZBH
Ingalls & Snyder LLC's ZBH Position: Q2 2024 in Review
Ingalls & Snyder LLC sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,533 shares — an estimated $202K sold.
Ingalls & Snyder LLC first reported a position in ZBH in Q2 2013 and held it in 38 quarters. The position peaked at $2.99M in Q1 2015. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.
- Ingalls & Snyder LLC reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
- Ingalls & Snyder LLC sold 1,533 Zimmer Biomet shares in Q2 2024, an estimated $202K.
- Ingalls & Snyder LLC first reported a position in Zimmer Biomet in Q2 2013 and held it in 38 quarters.
- Ingalls & Snyder LLC's Zimmer Biomet position peaked at $2.99M in Q1 2015.
- 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.
Based on Ingalls & Snyder LLC's 13F filing for Q2 2024, filed 31 Jul 2024.